Skip to main content

SRPT

Sarepta Therapeutics, Inc.
Last price
$17.25
As of

Active signals for SRPT

Top institutional holders of SRPT (13F)

FundMarket value% portfolioQoQ
TWO SIGMA INVESTMENTS, LP$99.9M0.08%+88.1%
TWO SIGMA INVESTMENTS, LP$52.5M0.07%+14.2%
RENAISSANCE TECHNOLOGIES LLC$51.1M0.07%,
TWO SIGMA INVESTMENTS, LP$41.2M0.06%,
RENAISSANCE TECHNOLOGIES LLC$36.2M0.06%+43.6%
D. E. Shaw & Co., Inc.$27.1M0.02%,
RENAISSANCE TECHNOLOGIES LLC$25M0.04%-56.2%
D. E. Shaw & Co., Inc.$15.5M0.01%+0.0%
D. E. Shaw & Co., Inc.$15.2M0.01%-45.3%
CITADEL ADVISORS LLC$12.9M0.00%,
CITADEL ADVISORS LLC$9.4M0.00%-34.4%
Bridgewater Associates, LP$6.8M0.03%,
Bridgewater Associates, LP$6M0.02%-20.4%
D. E. Shaw & Co., Inc.$5.8M0.00%,
Point72 Asset Management, L.P.$4.6M0.01%,
Point72 Asset Management, L.P.$4.5M0.01%-13.1%
Bridgewater Associates, LP$2.9M0.01%-52.1%
D. E. Shaw & Co., Inc.$2.8M0.00%+64.5%
D. E. Shaw & Co., Inc.$1.7M0.00%-74.5%
Point72 Asset Management, L.P.$675K0.00%-85.1%

Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.

Recent SEC filings, SRPT

See more SRPT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track SRPT in your watchlist and get notified the moment a new signal fires.

Track SRPT on Kresmion →